TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Tarsus Pharmaceuticals, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$69.50+1.43 (+2.10%)
Close on Oct 19, 2026
- Market cap
- $3.02B
- P/E (TTM)
- –
- Dividend yield
- 0.00%
SEC filings
40 of Tarsus Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 4, 2026 | Sep 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 6, 2026 | Jul 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2025 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2025 | Jan 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 13, 2024 | Apr 26, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 19, 2024 | Apr 23, 2024 | SEC EDGAR |